372 related articles for article (PubMed ID: 32297471)
1. Distinct HLA and non-HLA associations in different subtypes of ANCA-associated vasculitides in North India.
Singh J; Sharma A; Rani L; Kaur N; Anand S; Saikia B; Jha S; Nada R; Minz RW
Int J Rheum Dis; 2020 Jul; 23(7):958-965. PubMed ID: 32297471
[TBL] [Abstract][Full Text] [Related]
2. Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
Kawasaki A; Hasebe N; Hidaka M; Hirano F; Sada KE; Kobayashi S; Yamada H; Furukawa H; Yamagata K; Sumida T; Miyasaka N; Tohma S; Ozaki S; Matsuo S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
PLoS One; 2016; 11(5):e0154393. PubMed ID: 27166610
[TBL] [Abstract][Full Text] [Related]
3. Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
Merkel PA; Xie G; Monach PA; Ji X; Ciavatta DJ; Byun J; Pinder BD; Zhao A; Zhang J; Tadesse Y; Qian D; Weirauch M; Nair R; Tsoi A; Pagnoux C; Carette S; Chung S; Cuthbertson D; Davis JC; Dellaripa PF; Forbess L; Gewurz-Singer O; Hoffman GS; Khalidi N; Koening C; Langford CA; Mahr AD; McAlear C; Moreland L; Seo EP; Specks U; Spiera RF; Sreih A; St Clair EW; Stone JH; Ytterberg SR; Elder JT; Qu J; Ochi T; Hirano N; Edberg JC; Falk RJ; Amos CI; Siminovitch KA;
Arthritis Rheumatol; 2017 May; 69(5):1054-1066. PubMed ID: 28029757
[TBL] [Abstract][Full Text] [Related]
4. Association of
Kawasaki A; Sada KE; Kusumawati PA; Hirano F; Kobayashi S; Nagasaka K; Sugihara T; Ono N; Fujimoto T; Kusaoi M; Tamura N; Kusanagi Y; Itoh K; Sumida T; Yamagata K; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
Front Immunol; 2023; 14():1119064. PubMed ID: 36969218
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
[TBL] [Abstract][Full Text] [Related]
6. The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population.
Lundtoft C; Knight A; Meadows JRS; Karlsson Å; Rantapää-Dahlqvist S; Berglin E; Palm Ø; Haukeland H; Gunnarsson I; Bruchfeld A; Segelmark M; Ohlsson S; Mohammad AJ; Eriksson P; Söderkvist P; Ronnblom L; Omdal R; Jonsson R; Lindblad-Toh K; Dahlqvist J
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38580345
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis.
Li W; Huang H; Cai M; Yuan T; Sheng Y
Front Immunol; 2021; 12():624848. PubMed ID: 33841406
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
Kim SM; Choi SY; Kim SY; Kim J
Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
[TBL] [Abstract][Full Text] [Related]
10. Genetics of ANCA-associated vasculitides: HLA and beyond.
Alberici F; Martorana D; Bonatti F; Gioffredi A; Lyons PA; Vaglio A
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S90-7. PubMed ID: 24854378
[TBL] [Abstract][Full Text] [Related]
11. Risk HLA class II alleles and amino acid residues in myeloperoxidase-ANCA-associated vasculitis.
Wang HY; Cui Z; Pei ZY; Fang SB; Chen SF; Zhu L; Chen M; Chen N; Zhao MH
Kidney Int; 2019 Oct; 96(4):1010-1019. PubMed ID: 31471160
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690
[TBL] [Abstract][Full Text] [Related]
13. PR3-ANCA-associated vasculitis is associated with a specific motif in the peptide-binding cleft of HLA-DP molecules.
Gregersen JW; Erikstrup C; Ivarsen P; Glerup R; Krarup E; Keller KK; Hansen IT; Møller BK
Rheumatology (Oxford); 2019 Nov; 58(11):1942-1949. PubMed ID: 30938436
[TBL] [Abstract][Full Text] [Related]
14. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China.
Chang DY; Li ZY; Chen M; Zhao MH
Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibody-associated vasculitis classification by cluster analysis based on clinical phenotypes: a single-center retrospective cohort study.
Lee LE; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2024 Jan; 43(1):367-376. PubMed ID: 37530864
[TBL] [Abstract][Full Text] [Related]
16. HLA sequencing identifies novel associations and suggests clinical relevance of DPB1*04:01 in ANCA-associated Granulomatosis with polyangiitis.
Senapati S; Singh H; Bk T; Verma N; Kumar U
Gene; 2024 Feb; 896():148024. PubMed ID: 38040271
[TBL] [Abstract][Full Text] [Related]
17. Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis.
Carr EJ; Niederer HA; Williams J; Harper L; Watts RA; Lyons PA; Smith KG
BMC Med Genet; 2009 Dec; 10():121. PubMed ID: 19951419
[TBL] [Abstract][Full Text] [Related]
18. Associations of CTLA4 +49 A/G Dimorphism and HLA-DRB1*/DQB1* Alleles With Type 1 Diabetes from South India.
Padma-Malini R; Rathika C; Ramgopal S; Murali V; Dharmarajan P; Pushkala S; Balakrishnan K
Biochem Genet; 2018 Oct; 56(5):489-505. PubMed ID: 29603038
[TBL] [Abstract][Full Text] [Related]
19. HLA-DPB1 as a Risk Factor for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Cohort Study.
Hilhorst M; Arndt F; Joseph Kemna M; Wieczorek S; Donner Y; Wilde B; Thomas Epplen J; van Paassen P; Cohen Tervaert JW
Arthritis Rheumatol; 2016 Jul; 68(7):1721-30. PubMed ID: 26866715
[TBL] [Abstract][Full Text] [Related]
20. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.
Lionaki S; Blyth ER; Hogan SL; Hu Y; Senior BA; Jennette CE; Nachman PH; Jennette JC; Falk RJ
Arthritis Rheum; 2012 Oct; 64(10):3452-62. PubMed ID: 23023777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
